umbilical cord derived mesenchymal stem cell therapy (UC-MSC) / Tuohua Biological Technology - LARVOL DELTA

Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia (clinicaltrials.gov) - P2; N=16; Recruiting; Sponsor: ZhiYong Peng; N=10 ➔ 16; Trial completion date: Sep 2020 ➔ Dec 2020; Trial primary completion date: Apr 2020 ➔ Dec 2020

Clinical • Enrollment change • Trial completion date • Trial primary completion date • Infectious Disease • Novel Coronavirus Disease • Pneumonia • Respiratory Diseases • CD8 • CRP • CXCL8 • IL10 • IL4 • IL6 • TNFA